{"context":{"query":">>pharmgkb_gene>>pharmgkb","source_dataset":"pharmgkb_gene","target_dataset":"pharmgkb"},"stats":{"queried":1,"total":19,"mapped":1},"pagination":{"has_next":false},"schema":"id|name|type|clinical_annotation_count|variant_annotation_count|pathway_count","mappings":[{"input":"PA27006","source":"PA27006|cytotoxic T-lymphocyte associated protein 4","targets":["PA10004|adalimumab|Drug|18|118|0","PA10252|bortezomib|Drug|1|5|1","PA10832|corticosteroids|Drug Class|54|352|0","PA164712462|Antiinflammatory agents, non-steroids|Drug Class|31|141|0","PA164713366|Tumor necrosis factor alpha (TNF-alpha) inhibitors|Drug Class|122|508|0","PA164749390|peginterferon alfa-2a|Drug|31|211|1","PA164784024|peginterferon alfa-2b|Drug|41|289|1","PA165981594|eltrombopag|Drug|0|4|0","PA166179849|avatrombopag|Drug|0|8|1","PA449167|cyclosporine|Drug|26|157|2","PA449247|dexamethasone|Drug|14|55|2","PA449515|etanercept|Drug|15|99|0","PA449760|glatiramer acetate|Drug|3|14|0","PA450354|melphalan|Drug|2|4|0","PA451100|prednisone|Drug|13|66|1","PA451241|ribavirin|Drug|46|346|1","PA451261|rituximab|Drug|10|55|0","PA451578|tacrolimus|Drug|82|1120|2","PA452639|infliximab|Drug|21|128|0"]}]}